A nasal vaccine for COVID-19 – based on technology developed at Washington University in St. Louis – is poised to enter a phase 1 clinical trial in the U.S. after an investigational new drug ...
The adenovirus carries the SARS-CoV-2 protein into the nose ... vaccine and subsequently infected did not pass the virus on to others, breaking the cycle of transmission. “All effective vaccines ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback